Differential expression of the AP-1 transcription factor family members in human colorectal epithelial and neuroendocrine neoplasms.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  American Journal of Clinical Pathology

• Publication date

  2005-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1309/T1H2Y2CHWY7PD2BNPMID 15923159
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dominant-negative mutant of c-Jun gene transfer: a novel therapeutic strategy for colorectal cancer

  2004cited by this paper
• Analysis of Protein Expression and Gene Mutation of c-kit in Colorectal Neuroendocrine Carcinomas

  2003cited by this paper
• Promising molecular targets for cancer prevention: AP-1, NF-kappa B and Pdcd4.

  2003cited by this paper
• COX-2 and colorectal cancer.

  2003cited by this paper
• AP-1: a double-edged sword in tumorigenesis

  2003cited by this paper
• Promising molecular targets for cancer prevention: AP-1, NF-κB and Pdcd4

  2003cited by this paper
• AP-1 as a regulator of cell life and death

  2002cited by this paper
• β-catenin - A linchpin in colorectal carcinogenesis?

  2002cited by this paper
• Beta-catenin--a linchpin in colorectal carcinogenesis?

  2002cited by this paper
• Promoter Specificity and Biological Activity of Tethered AP-1 Dimers

  2002cited by this paper
• Elevated protein expression of cyclin D1 and Fra‐1 but decreased expression of c‐Myc in human colorectal adenocarcinomas overexpressing β‐catenin

  2002cited by this paper
• Jun, the oncoprotein

  2001cited by this paper
• The mammalian Jun proteins: redundancy and specificity

  2001cited by this paper
• Distinct roles of Jun : Fos and Jun : ATF dimers in oncogenesis

  2001cited by this paper
• AP-1 in cell proliferation and survival

  2001cited by this paper
• Activator Protein-1 Transcription Factor Mediates Bombesin-stimulated Cyclooxygenase-2 Expression in Intestinal Epithelial Cells*

  2001cited by this paper
• AP-1 in mouse development and tumorigenesis

  2001cited by this paper
• The role of bile acids in carcinogenesis.

  2001cited by this paper
• Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity

  2001cited by this paper
• The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis.

  2000cited by this paper
• Genetic syndromes and genetic tests in colorectal cancer.

  2000cited by this paper
• Bile Acid-induced Activation of Activator Protein-1 Requires Both Extracellular Signal-regulated Kinase and Protein Kinase C Signaling*

  2000cited by this paper
• Expression of Jun family members in human colorectal adenocarcinoma.

  2000cited by this paper
• Fos family members: regulation, structure and role in oncogenic transformation.

  2000cited by this paper
• Transcriptional regulation of cell invasion: AP-1 regulation of a multigenic invasion programme.

  2000cited by this paper
• Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas.

  1999cited by this paper
• Effects of colonic lumenal components on AP-1-dependent gene transcription in cultured human colon carcinoma cells.

  1999cited by this paper
• Nuclear translocation of Fos is stimulated by interaction with Jun through the leucine zipper

  1999cited by this paper
• Overexpression of fra-2 in transgenic mice perturbs normal eye development

  1998cited by this paper
• AP-1 function and regulation.

  1997cited by this paper
• Concordance of genetic alterations in poorly differentiated colorectal neuroendocrine carcinomas and associated adenocarcinomas.

  1997cited by this paper
• Oncogene expression in gastroenteropancreatic neuroendocrine tumors

  1997cited by this paper
• Lessons from Hereditary Review Colorectal Cancer

  1996cited by this paper
• Induction of the transcription factor AP-1 in cultured human colon adenocarcinoma cells following exposure to bile acids.

  1996cited by this paper
• Transcription factor AP‐1, and the role of Fra‐2

  1996cited by this paper
• Immunol. Cell Biol.

  1995cited by this paper
• Activation of the Nuclear Oncogenes N-myc and c-jun in Cartinoid Tumors of Transgenic Mice Carrying the Human Adenovirus Type 12 E1 Region Gene

  1995cited by this paper
• Activation of the nuclear oncogenes N-myc and c-jun in carcinoid [correction of cartinoid] tumors of transgenic mice carrying the human adenovirus type 12 E1 region gene.

  1995cited by this paper
• Association of genetic alterations of c-myc, c-fos, and c-Ha-ras proto-oncogenes in colorectal tumors

  1992cited by this paper
• The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation.

  1991cited by this paper
• Expression of c-myc and c-fos mRNA in colorectal carcinoma in man

  1990cited by this paper
• Expression of c‐myc oncogene in colorectal polyps as a biological marker for monitoring malignant potential

  1989cited by this paper
• Differential expression of c-myc gene and c-fos gene in premalignant and malignant tissues from patients with familial polyposis coli.

  1988cited by this paper
• Oncogene expression in adenocarcinomas of the colon and in colon tumor-derived cell lines.

  1988cited by this paper
• Prognostic implications of expression of the cellular genes myc, fos, Ha‐ras and Ki‐ras in colon carcinoma

  1987cited by this paper

• The Oncoprotein Fra-2 Drives the Activation of Human Endogenous Retrovirus Env Expression in Adult T-Cell Leukemia/Lymphoma (ATLL) Patients

  2024cites this paper
• The complex network of transcription factors, immune checkpoint inhibitors and stemness features in colorectal cancer: A recent update.

  2023cites this paper
• Genomic Loss and Epigenetic Silencing of the FOSL1 Tumor Suppressor Gene in Radiation-induced Neoplastic Transformation of Human CGL1 Cells Alters the Tumorigenic Phenotype In Vitro and In Vivo

  2023cites this paper
• Role of Fra-2 in cancer

  2023cites this paper
• Exploring the mechanism of action of Yiyi Fuzi Baijiang powder in colorectal cancer based on network pharmacology and molecular docking studies

  2023cites this paper
• Fra-2 overexpression upregulates pro-metastatic cell-adhesion molecules, promotes pulmonary metastasis, and reduces survival in a spontaneous xenograft model of human breast cancer

  2021cites this paper
• Transcription factors in colorectal cancer: molecular mechanism and therapeutic implications

  2020cites this paper
• IL‐17R deletion predicts high‐grade colorectal cancer and poor clinical outcomes

  2019cites this paper
• Forskolin and Phorbol 12-myristate 13-acetate modulates the expression pattern of AP-1 factors and cell cycle regulators in estrogen-responsive MCF-7 cells

  2018cites this paper
• Therapeutic targeting of tumor cell plasticity in colorectal cancer

  2018cites this paper
• Regulation of HPGD and SLCO2A1 in colorectal cancer development

  2018influential citation
• A case study of apparent immune activation following treatment of a colorectal cancer patient with an angiotensin receptor blocker

  2018cites this paper
• Fra-1 enhances the radioresistance of colon cancer cells to X-ray or C-ion radiation

  2018cites this paper
• Oncogenic Effects of High MAPK Activity in Colorectal Cancer Mark Progenitor Cells and Persist Irrespective of RAS Mutations.

  2017cites this paper
• Role of Transcription Factors in Gastrointestinal Malignancies

  2017influential citation
• Antineoplastic effects of histone deacetylase inhibitors in neuroendocrine cancer cells are mediated through transcriptional regulation of Notch1 by activator protein 1

  2017cites this paper
• Transcription Factors and Colorectal Cancer: An Overview

  2017cites this paper
• Response to angiotensin blockade with irbesartan in a patient with metastatic colorectal cancer

  2016cites this paper
• Immunohistological Analysis of the Jun Family and the Signal Transducers and Activators of Transcription in Thymus

  2015cites this paper
• Non-digestible carbohydrates, the WNT signalling pathway and bowel cancer risk

  2015cites this paper
• The A Allele at rs13419896 of EPAS1 Is Associated with Enhanced Expression and Poor Prognosis for Non-Small Cell Lung Cancer

  2015cites this paper
• The A Allele at rs 13419896 of EPAS 1 Is Associated with Enhanced Expression and Poor Prognosis for Non-Small Cell Lung Cancer

  2015cites this paper
• Quantitative proteomic analysis for high-throughput screening of differential glycoproteins in hepatocellular carcinoma serum

  2015cites this paper
• Conference on ‘ Carbohydrates in health : friends or foes ’ Postgraduate symposium Is resistant starch protective against colorectal cancer via modulation of the WNT signalling pathway ?

  2015cites this paper
• Activation of Akt at T308 and S473 in alcohol, tobacco and HPV-induced HNSCC: is there evidence to support a prognostic or diagnostic role?

  2014cites this paper
• Widespread FRA1-Dependent Control of Mesenchymal Transdifferentiation Programs in Colorectal Cancer Cells

  2014cites this paper
• Delayed post-ischaemic administration of xenon reduces brain damage in a rat model of global ischaemia

  2014cites this paper
• Atlas of Genetics and Cytogenetics in Oncology and Haematology

  2014cites this paper
• Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER).

  2013cites this paper
• Atlas of Genetics and Cytogenetics in Oncology and Haematology FOSL 1 ( FOS-like antigen 1 )

  2013influential citation
• FOSL1 (FOS-like antigen 1)

  2013cites this paper
• Investigating downstream effectors of KRas signalling in vivo : Dusp6 and Fra1

  2012cites this paper
• The molecular role of Fra‐1 and its prognostic significance in human esophageal squamous cell carcinoma

  2012cites this paper
• Fra-1 controls motility of bladder cancer cells via transcriptional upregulation of the receptor tyrosine kinase AXL

  2012cites this paper
• Fra-1 promotes breast cancer chemosensitivity by driving cancer stem cells from dormancy.

  2012cites this paper
• Pdcd4 knockdown up-regulates MAP4K1 expression and activation of AP-1 dependent transcription through c-Myc.

  2012cites this paper
• c-JUN promotes BCR-ABL-induced lymphoid leukemia by inhibiting methylation of the 5' region of Cdk6.

  2011cites this paper
• Functional variants of -1318T > G and -673C > T in c-Jun promoter region associated with increased colorectal cancer risk by elevating promoter activity.

  2011cites this paper
• Cooperation between the thyroid hormone receptor TRalpha1 and the WNT pathway in the induction of intestinal tumorigenesis.

  2010cites this paper
• Fos-related activator-1 is overexpressed in oral squamous cell carcinoma and associated with tumor lymph node metastasis.

  2010cites this paper
• The transcription factor Fra-2 promotes mammary tumour progression by changing the adhesive properties of breast cancer cells.

  2010cites this paper
• Immunoreactivity of ATF-2 and Fra-2 in human dental follicle.

  2010cites this paper
• Junb regulates arterial contraction capacity, cellular contractility, and motility via its target Myl9 in mice.

  2010cites this paper
• Emerging roles of ATF2 and the dynamic AP1 network in cancer

  2010cites this paper
• High expression of Foxp3, IL-23p19 and survivin mRNA in colorectal carcinoma

  2009cites this paper
• Signaling and regulation of cysteinyl leukotriene receptors in intestinal epithelial cells and colon cancer

  2009cites this paper
• Clinicopathological significance of expression of p-c-Jun, TCF4 and beta-Catenin in colorectal tumors

  2008cites this paper
• Targeting c-Jun and JunB proteins as potential anticancer cell therapy

  2008cites this paper
• Hierarchical cluster analysis of myoepithelial/basal cell markers in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma

  2008cites this paper
• AP-1 a target for cancer prevention.

  2007cites this paper
• PTEN and phosphorylated AKT expression and prognosis in early- and late-stage non-small cell lung cancer.

  2007cites this paper
• Fra-1 a target for cancer prevention or intervention.

  2006cites this paper
• Digital Commons

  year unknowncites this paper